Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Vicarious Surgical (RBOT)
NYSE:RBOT
Holding RBOT?
Track your performance easily
RBOT Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$4.27 - $21.45
Previous Close$11.49
Volume37.81K
Average Volume (3M)19.30K
Market Cap
$67.89M
Enterprise Value$21.08M
Total Cash (Recent Filing)$60.86M
Total Debt (Recent Filing)$14.06M
Price to Earnings (P/E)―
Beta3.02
Next Earnings
Feb 27, 2025EPS Estimate
-$2.75Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-5.66
Shares Outstanding5,908,219
10 Day Avg. Volume37,028
30 Day Avg. Volume19,296
Standard Deviation0.21
R-Squared0.05
Alpha-0.06
Financial Highlights & Ratios
Price to Book (P/B)0.92
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-1.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-0.75
Forecast
1Y Price Target
$11.17Price Target Upside-2.79% Downside
Rating ConsensusHold
Number of Analyst Covering4
Vicarious Surgical News
PremiumCompany Announcements
Vicarious Surgical Inc. Reports Q3 2024 Financial Results
Bulls Say, Bears Say
Bulls Say
Financial ManagementRBOT continues to manage its cash position responsibly, ensuring sufficient funds through key milestones and stable cash management.
PartnershipsRBOT's recent partnership with LSU Health New Orleans establishes its fifth hospital alliance, enhancing its collaborative network.
Product DevelopmentThe final integration of the Version 1.0 System is just weeks away, positioning the company to advance towards testing and its first clinical patient experience.
Bears Say
Financial PerformanceRBOT reported zero revenue and a larger loss per share than expected, missing both BTIG and consensus estimates.
Financing ConcernsFinancing concerns weigh on the stock as RBOT has enough cash only until fiscal year 2026, but will not be commercial until fiscal year 2027.
Product Development DelaysDelays in product development amid a challenging macroeconomic environment suggest investors might prefer to stay on the sidelines.
---
Ownership Overview
48.85% Insiders
3.77% Mutual Funds
29.79% Other Institutional Investors
14.78% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
RBOT FAQ
What was Vicarious Surgical’s price range in the past 12 months?
Vicarious Surgical lowest stock price was $4.27 and its highest was $21.45 in the past 12 months.
What is Vicarious Surgical’s market cap?
Currently, no data Available
When is Vicarious Surgical’s upcoming earnings report date?
Vicarious Surgical’s upcoming earnings report date is Feb 27, 2025 which is in 92 days.
How were Vicarious Surgical’s earnings last quarter?
Vicarious Surgical released its earnings results on Nov 12, 2024. The company reported -$2.877 earnings per share for the quarter, missing the consensus estimate of -$2.575 by -$0.302.
Is Vicarious Surgical overvalued?
According to Wall Street analysts Vicarious Surgical’s price is currently Overvalued.
Does Vicarious Surgical pay dividends?
Vicarious Surgical does not currently pay dividends.
What is Vicarious Surgical’s EPS estimate?
Vicarious Surgical’s EPS estimate is -$2.75.
How many shares outstanding does Vicarious Surgical have?
Vicarious Surgical has 5,254,229 shares outstanding.
What happened to Vicarious Surgical’s price movement after its last earnings report?
Vicarious Surgical reported an EPS of -$2.877 in its last earnings report, missing expectations of -$2.575. Following the earnings report the stock price went down -17.864%.
Which hedge fund is a major shareholder of Vicarious Surgical?
Among the largest hedge funds holding Vicarious Surgical’s share is Aristeia Capital LLC. It holds Vicarious Surgical’s shares valued at N/A.
---
Vicarious Surgical Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$11.17 (-2.79% Downside)
$11.17 (-2.79% Downside)
Insider Transactions
Sold Shares
Worth $21.5K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▲ 0.3%
Last 30 Days ▼ 1.2%
Last 30 Days ▼ 1.2%
Technicals
SMA
Positive
20 days / 200 days
Momentum
5.50%
12-Months-Change
Fundamentals
Return on Equity
-75.30%
Trailing 12-Months
Asset Growth
-38.95%
Trailing 12-Months
Company Description
Vicarious Surgical
D8 Holdings Corp is a blank check company.
---
RBOT Earnings Call
Q3 2024
0:00 / 0:00
---
RBOT Stock 12 Month Forecast
Average Price Target
$11.17
▼(-2.79% Downside)
Technical Analysis
Best Analysts Covering RBOT
1 Year
1 Year Success Rate
5/6 ratings generated profit
1 Year Average Return
+27.85%
assigned a buy rating 14 days ago
Copying Josh Jennings's trades and holding each position for 1 Year would result in 83.33% of your transactions generating a profit, with an average return of +27.85% per trade.
---